Mostrar el registro sencillo

dc.contributor.authorPuente Ruiz, Nuriaes_ES
dc.contributor.authorDocio Pérez, Pabloes_ES
dc.contributor.authorGarcía Unzueta, María Teresa es_ES
dc.contributor.authorLavín Gómez, Bernardo Alioes_ES
dc.contributor.authorMaiztegi, Ainhoaes_ES
dc.contributor.authorVega, Ana Isabeles_ES
dc.contributor.authorPiedra, Maríaes_ES
dc.contributor.authorRiancho Zarrabeitia, Leyrees_ES
dc.contributor.authorMateos, Fátimaes_ES
dc.contributor.authorGonzález-Lamuño Leguina, Domingo es_ES
dc.contributor.authorValero Díaz de Lamadrid, Carmen es_ES
dc.contributor.authorRiancho Moral, José Antonio es_ES
dc.contributor.otherUniversidad de Cantabriaes_ES
dc.date.accessioned2023-08-25T07:49:04Z
dc.date.available2023-08-25T07:49:04Z
dc.date.issued2023es_ES
dc.identifier.issn0954-6820es_ES
dc.identifier.issn1365-2796es_ES
dc.identifier.urihttps://hdl.handle.net/10902/29763
dc.description.abstractBackground Chronic hypophosphatemia can result from a variety of acquired disorders, such as malnutrition, intestinal malabsorption, hyperparathyroidism, vitamin D deficiency, excess alcohol intake, some drugs, or organ transplantation. Genetic disorders can be a cause of persistent hypophosphatemia, although they are less recognized. We aimed to better understand the prevalence of genetic hypophosphatemia in the population. Methods By combining retrospective and prospective strategies, we searched the laboratory database of 815,828 phosphorus analyses and included patients 17-55 years old with low serum phosphorus. We reviewed the charts of 1287 outpatients with at least 1 phosphorus result ≤2.2 mg/dL. After ruling out clear secondary causes, 109 patients underwent further clinical and analytical studies. Among them, we confirmed hypophosphatemia in 39 patients. After excluding other evident secondary causes, such as primary hyperparathyroidism and vitamin D deficiency, we performed a molecular analysis in 42 patients by sequencing the exonic and flanking intronic regions of a panel of genes related to rickets or hypophosphatemia (CLCN5, CYP27B1, dentin matrix acidic phosphoprotein 1, ENPP1, FAM20C, FGFR1, FGF23, GNAS, PHEX, SLC34A3, and VDR). Results We identified 14 index patients with hypophosphatemia and variants in genes related to phosphate metabolism. The phenotype of most patients was mild, but two patients with X-linked hypophosphatemia (XLH) due to novel PHEX mutations had marked skeletal abnormalities. Conclusion Genetic causes should be considered in children, but also in adult patients with hypophosphatemia of unknown origin. Our data are consistent with the conception that XLH is the most common cause of genetic hypophosphatemia with an overt musculoskeletal phenotype.es_ES
dc.format.extent10 p.es_ES
dc.language.isoenges_ES
dc.publisherOxford Blackwell Scientifices_ES
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.sourceJournal of internal medicine, 2023, 293(6), 753-762es_ES
dc.subject.otherFamilial hypophosphatemiaes_ES
dc.subject.otherFibroblastgrowth factor 23es_ES
dc.subject.otherPhosphatees_ES
dc.subject.otherVitamin Des_ES
dc.subject.otherX-linkedhypophosphatemiaes_ES
dc.titleUncovering genetic causes of hypophosphatemiaes_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.relation.publisherVersionhttps://doi.org/10.1111/joim.13635es_ES
dc.rights.accessRightsopenAccesses_ES
dc.identifier.DOI10.1111/joim.13635es_ES
dc.type.versionpublishedVersiones_ES


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo

Attribution-NonCommercial-NoDerivatives 4.0 InternationalExcepto si se señala otra cosa, la licencia del ítem se describe como Attribution-NonCommercial-NoDerivatives 4.0 International